Patch treats depression
Patients now have more options to treat major depression after federal officials approved the first antidepressant skin patch. The Food and Drug Administration approved the once-a-day skin patch expected to be available to consumers in April that delivers Emsam, a monoamine oxidase inhibitor, through the skin and into the bloodstream at a constant rate. Greta DeWolf, National Alliance on Mental Illness of Michigan vice president, said the patch offers another option for patients who are resistant to other antidepressants.